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Objectives: Percutaneous aortic valve insertion is an emerging treatment option for selected patients with severe
aortic stenosis and may be done from a transfemoral or transapical approach. Concomitant atherosclerotic periph-
eral artery disease limits transfemoral access. We evaluated the potential role of multidetector computed tomog-
raphy in preoperative assessment of vascular anatomy.
Methods: Consecutive patients with severe aortic stenosis were included. Contrast-enhanced computed tomo-
graphic angiography of the thoracic and abdominal aorta and iliofemoral arteries was performed. Criteria of
unfavorable iliofemoral anatomy were defined as a minimal luminal diameter of the common iliac, external iliac,
or common femoral arteries of less than 8 mm, presence of greater than 60% circumferential calcification at the
external–internal iliac bifurcation, and severe angulation between the common and external iliac arteries (<90).
The prevalence of these criteria was evaluated and infrarenal aortic and iliofemoral arterial anatomy was com-
pared in the groups with and without peripheral artery disease for any of these criteria.
Results:One hundred patients (79 9 years, 59%male) were included. A total of 35 (35%) patients had at least
one criterion of unsuitable iliofemoral anatomy, including 27 patients with small minimal luminal diameter
(<8 mm), 12 patients with severe circumferential calcification at the iliac bifurcation (>60%), and 4 with severe
angulation of the iliac arteries (<90).
Conclusions: Significant atherosclerotic peripheral artery disease is common in the high-risk patient population
currently evaluated for percutaneous aortic valve insertion. Computed tomography allows identification of pa-
tients with iliofemoral anatomy unfavorable for the transfemoral approach to percutaneous aortic valve insertion.
EVOLVING TECHNOLOGYE
TPercutaneous aortic valve insertion (pAVI) is an emerging
therapy for selected patients with severe aortic stenosis
who are not candidates for conventional open cardiac
surgery owing to significant comorbidities.1-8 There is
a spectrum of arterial access strategies, ranging from a percu-
taneous transfemoral approach, open femoral/iliac approach,
surgical iliac grafts, to a transapical approach.9-11 Because of
the large device size of current generation systems, the trans-
femoral approach requires favorable iliofemoral arterial
anatomy.12 In the setting of insufficient luminal diameter
but also extensive calcification and tortuosity of the iliofe-
moral arteries, the transfemoral approach is associated
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of significant peripheral arterial disease (PAD) in the high-
risk population currently undergoing assessment for pAVI
is unknown but expected to be high.
Limited angiographic assessment of the iliofemoral anat-
omy is routinely performed during preprocedural coronary
angiography. However, dedicated evaluation of infrarenal
aortic and iliofemoral arterial anatomy by multidetector
computed tomography (MDCT) might have additional value
inasmuch as it allows precise cross-sectional diameter mea-
surements, assessment of the extent and distribution of
calcification, and 3-dimensional course/tortuosity of the ilio-
femoral arteries. This may allow identification of patients
with unsuitable iliofemoral anatomy for a transfemoral
approach to pAVI and eventually preprocedural planning
of arterial access.
The aim of this study was to evaluate the prevalence and
characteristics of PAD using computed tomographic (CT)




We evaluated 100 consecutive patients with severe, symptomatic aortic
stenosis who were referred for MDCT as part of the evaluation for pAVI.
Patients with advanced renal insufficiency or other contraindications torgery c May 2009
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TAbbreviations and Acronyms
CT ¼ computed tomography
MDCT ¼ multidetector computed tomography
pAVI ¼ percutaneous aortic valve insertion
PAD ¼ peripheral arterial disease
intravenous contrast dye were excluded from the MDCT evaluation. The
study was approved by the institutional review board, with waiver of indi-
vidual consent.
Dual-Source MDCT
All subjects were scanned on a dual-source multidetector row CT scan-
ner (MDCT; Siemens Medical Solutions, Definition, Erlangen, Germany)
after administration of an iodinated contrast agent (70–100 mL of Ultravist
370) at 3 mL/s. All patients were scanned from the level of the thoracic inlet
to the level of the mid-thigh region using a nonelectrocardiographically
gated helical mode of acquisition with the following parameters: gantry ro-
tation time ¼ 330 ms; beam collimation ¼ 24 3 1.2 mm; tube voltage ¼
120 kVp; reference tube current ¼ 170 effective mAs with anatomic based
tube current modulation; beam pitch¼ 0.6. Images were reconstructed with
3-mm slice thickness.
MDCT Data Analysis
The images were analyzed offline by two investigators (V.K., S.S.) on
a dedicated workstation (Siemens Leonardo). The investigators were
blinded to the subject’s clinical status and the angiographic images. The in-
frarenal abdominal aorta, bilateral common iliac arteries, external iliac ar-
teries, and common femoral arteries were evaluated for the following
characteristics: (1) minimal luminal diameter (measured from true short-
axis double oblique images, orthogonal to the vessel center line; the window
center and level were adjusted to reduce the effect of calcium blooming on
vessel measurements; (2) circumferential extent of calcification at the ab-
dominal aortic bifurcation and at the common iliac artery bifurcation (bifur-
cation into the external and internal iliac arteries); and (3) tortuosity of the
arteries defined by the angle between the common iliac artery and external
iliac artery (Figures 1–4).
Prespecified Criteria of Significant PAD
At the onset of the study, unfavorable iliofemoral anatomy was defined
as at least one of the following criteria: minimal luminal diameter of the
common iliac, external iliac, or common femoral arteries less than 8 mm,
presence of more than 60% circumferential calcification at the external–
internal iliac bifurcation, and severe angulation between the common and
external iliac arteries (<90) (Figures 1–4).
Statistical Analysis
All values presented are the mean  standard deviation for continuous
variables and the percentage of total patients for categorical variables.
The independent sample t test and c2 test were used for comparison of suit-
able and unsuitable patient groups. All P values were 2-sided. Calculations
were performed with Statistical Package for the Social Sciences (SPSS)
software (version 12.0, SPSS, Inc, Chicago, Ill).
RESULTS
We included 100 consecutive patients (79 9 years, 59%
male). The mean logistic EuroSCORE14 was 21.1  14.3.
Thirty-five (35%) patients had at least one of the above-
described criteria of significant PAD (PAD group) and 65The Journal of Thoracic and Cpatients did not meet any criteria for severe PAD (no-PAD
group). The PAD group had a statistically significantly
higher incidence of coronary artery disease, hypertension,
diabetes, chronic obstructive pulmonary disease, prior
stroke, obesity, and smoking history than the no-PAD group
(Table 1). Because of the long and variable scan ranges re-
quired for aortic imaging, typical dose length product values
ranged from approximately 600 to 1000 mGy 3 cm.
In the PAD group, 27 (77%) patients had a minimal lumi-
nal diameter of less than 8mm in at least one location. Twelve
(34%) patients had severe calcification at the iliac bifurca-
tion, including 9 patients who had severe bilateral calcifica-
tion. Four (11%) patients had severe (<90) angulation at
the common iliac artery and external iliac artery. The mean
angle between the right common iliac artery and external iliac
arterywas 115  20. Themean angle between the left com-
mon iliac artery and external iliac artery was 120  17.
Among the 35 patients with unfavorable anatomy, 7 (20%)
had more than one of these criteria and 2 (6%) had all three
criteria. Of these 35 patients, 8 patients also had significant
atherosclerotic changes of the abdominal aorta, including ex-
treme tortuous course of the infrarenal abdominal aorta (n¼
4; 11%), infrarenal abdominal aortic aneurysm diameter
greater than 3.5 cm (n ¼ 2, 6%), and infrarenal penetrating
ulceration (n ¼ 2; 6%).
Comparison between the group of patients with (PAD
group/unfavorable anatomy) and without (no-PAD group/
favorable anatomy) any of these criteria showed significant
differences of clinical characteristics and anatomy of the in-
frarenal and iliofemoral arteries. In the PAD group, the mean
luminal diameter at several levels including the infrarenal
abdominal aorta, common iliac arteries, external iliac ar-
teries, and common femoral arteries was significantly
smaller than in the no-PAD group (Table 2). In the PAD
group, 6 (17%) patients had infrarenal abdominal aorta
FIGURE 1. Normal infrarenal aortic and iliac anatomy. The angulation
between the common and external iliac artery is illustrated.ardiovascular Surgery c Volume 137, Number 5 1259
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TFIGURE 2. Volume-rendered image (A), coronary (B), and axial (C) images of the aortic bifurcation. Volume-rendered image (D), coronary (E), and axial
(F) images of the iliac bifurcation.luminal diameter less than 12 mm, 7 (20%) patients had
dense calcification at the aortic bifurcation, and 12 (34%)
patients had dense calcification (>60%) at iliac bifurcation.
In contrast, in the no-PAD group, none (0%) of the patients
had a luminal diameter of the abdominal aorta less than 12
mm, and 5 (8%) patients had dense calcification at the aortic
bifurcation (Table 3).
Of the 35 patients with MDCT criteria of unfavorable
iliofemoral anatomy, 5 patients underwent pAVI via a
transfemoral approach. Of these 5 patients, 2 had vascular
complications related to the access site (bleeding, focal dis-
section) requiring surgical intervention. The remaining 3
patients had no procedural complications. In contrast, of
the 65 patients without high-risk MDCT criteria, 7 patients
underwent transfemoral pAVI. Of these 7 patients, only 1
had a vascular complication (P value ¼ not significant).
DISCUSSION
Using CT angiography of the infrarenal abdominal aorta
and iliofemoral arteries, we found that one third of patients1260 The Journal of Thoracic and Cardiovascular Swith severe aortic stenosis evaluated for pAVI had ana-
tomic criteria of unfavorable atherosclerotic iliofemoral
disease. Of these patients, a majority (77%) demonstrated
small luminal narrowing (<8 mm) of the iliofemoral ar-
teries; the remaining 23% showed other criteria of ad-
vanced disease, including circumferential calcification and
severe tortuosity, despite sufficient luminal diameter. Com-
parison between the groups of patients with and without
any of these criteria demonstrated that the presence of
any one of these criteria identifies a high-risk group of pa-
tient with significantly higher clinical risk profile and more
unfavorable anatomy of the entire infrarenal and iliofemoral
arteries.
At the current time, pAVI is limited to selected patients
with severe aortic stenosis who have a risk of death exceed-
ing 15% with conventional surgery and are not candidates
for traditional open cardiac surgery.1-11 These patients con-
stitute a high-risk population with significant short-term
mortality.15-17 Because of the known overlap of etiology
and risk factors for atherosclerotic vascular disease andurgery c May 2009
Kurra et al Evolving TechnologyFIGURE 3. Severe atherosclerotic changes of the infrarenal abdominal aorta and iliac arteries. The left panel shows a volume rendered image. The middle
panel shows a coronary multiplanar reconstruction (MPR). The right sided panels show axial MPR images at the level of the infrarenal abdominal aorta, aortic
and iliac bifurcation. CIA, Common iliac artery.aortic stenosis, it is not surprising to find a high number of
patients with PAD in this population.18 Advanced PAD
has been associated with increased risk of peripheral compli-
cations in other endovascular procedures.12 In fact, in one of
the first reports of successful human pAVI in a patient with
aortic stenosis and pre-existing PAD, progressive worsening
of the leg ischemia, leg amputation with lack of healing, in-
fection, and death 17 weeks after PHV implantation was
reported.19
Preprocedural understanding of arterial anatomy is impor-
tant to avoid these complications, in particular because there
is a spectrum of alternative arterial access strategies, rangingThe Journal of Thoracic and Cafrom a percutaneous transfemoral approach, open femoral
approach, surgical iliac access grafts, to a transapical ap-
proach. Current devices are still relatively large, and advanc-
ing these large and relatively stiff devices is limited not only
by luminal diameter, but also by vessel calcification (and
subsequent distensibility) and tortuosity. Although limited
iliofemoral angiography is routinely used in the preoperative
assessment of these patients, evaluation of iliofemoral
anatomy by MDCT allows more definitive assessment of
the 3-dimensional course of the pelvic arteries and distribu-
tion and extent of calcification. Data about preprocedural
imaging in the context of pAVI is limited. However,E
TFIGURE 4. Volume-rendered images demonstrating a patient with steep and shallow angle between the common and external iliac arteries. CIA, Common
iliac artery; EIA, external iliac artery.rdiovascular Surgery c Volume 137, Number 5 1261
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TTABLE 1. Baseline demographics of the 100 patients with aortic stenosis and in the groups with (PAD group) and without (no-PAD group) criteria
of significant PAD
Characteristic All patients (n ¼ 100) PAD group (n ¼ 35) No-PAD group (n ¼ 65) P value (PAD vs no-PAD)
Age (y) 79  9 78  7 80  9 .07
Male gender,% (n) 59% (59) 48% (17) 60% (42) .02
Body mass index 27.9  3.2 28.6  3.8 26.6  3.5 .02
Diabetes,% (n) 44% (44) 52% (16) 41% (28) .02
Hypertension,% (n) 74% (74) 80% (28) 70% (46) .02
Dyslipidemia,% (n) 72% (72) 60% (21) 78% (51) .5
Prior stroke,% (n) 9% (9) 12% (4) 7% (5) .05
Prior MI,% (n) 14% (14) 20% (7) 11% (7) <.01
Prior CABG,% (n) 42% (42) 40% (14) 43% (28) .04
Severe COPD,% (n) 40% (41) 46% (16) 38% (25) .02
Smoking history,% (n) 60% (60) 71% (25) 52% (35) .03
Previous cardiac surgery,% (n) 58% (58) 54% (19) 60% (39) .08
Logistic EuroSCORE 21.1  14.3 18.1  12.3 22.3  14.2 .81
CAD,% (n) 78% (78) 86% (30) 74% (48) .001
LVEF (%) 48  14 50  9 48  13 <.001
Peak gradient 75  26 78  22 72  24 .3
AVA (cm2) 0.7  0.2 0.6  0.1 0.7  0.2 .01
Creatinine (mg/dL) 1.1  0.4 1.1  0.6 1.0  0.3 <.001
PAD, Peripheral arterial disease;MI,myocardial infarction; CABG, coronary artery bypass grafting; COPD, chronic obstructive pulmonary disease; CAD, coronary artery disease;
LVEF, left ventricular ejection fraction; AVA, aortic valve area.preprocedural interventional planning is widely established
and routinely performed in the context of aortic endova-
scular stent procedures, and it gains importance for novel
surgical and interventional procedures, including hybrid sur-
gical/endovascular procedures and robotic surgery.20-23
The importance for planning of vascular access may di-
minish with the development of pAVI valve delivery sys-
tems with small diameters. However, our data suggest that
the identification of the above-described criteria of unfavor-
able iliofemoral anatomy may identify a high-risk group of
patients in whom careful planning of access strategy may
be of particular importance.
LIMITATIONS
The criteria used to define unfavorable iliofemoral anat-
omy in the current study were arbitrarily defined by consen-
sus of the investigators at the onset of the study. These1262 The Journal of Thoracic and Cardiovascular Sucriteria were based on a review of the literature13 and also
current size of the sheaths used in the procedure. For the
transfemoral approach, the external diameter for the 23-
mm Edwards stent valve insertion sheath (Edwards Life-
Sciences, Irvine, Calif) is 24F (7.7-mm diameter) and for
the 26-mm stent valve, the external sheath size is 28F (9.0
mm). Assuming some arterial distensibility, a cutoff of 8
mm was initially deemed reasonable. However, with in-
creasing experience, this approach appears conservative
and access through vessels of 7 mm or more (in the absence
of circumferential calcification) has been successful. The
current study was not designed to define precise inclusion/
exclusion criteria or to examine whether these criteria corre-
lated with screening angiogram. Procedural and clinical out-
come and the reported outcome data are preliminary. Results
from ongoing and future clinical studies will need to define
the prognostic value of high-risk criteria on clinical outcomeTABLE 2. Mean luminal diameter of the infrarenal abdominal aorta and iliofemoral arteries in the overall group and in the groups with (PAD
group) and (no-PAD group) criteria of significant PAD
Mean luminal diameter (mm ± SD)
Arterial segment (mm) All patients (n ¼ 100) PAD group (n ¼ 35) No-PAD group (n ¼ 65) P value (PAD vs no-PAD)
Infrarenal abdominal aorta 16.4  2.7 15.2  2.6 17.2  2.9 .02
Right common iliac artery 10.6  1.8 9.4  1.8 11.3  1.5 .01
Right external iliac artery 8.6  1.4 7.1  1.1 9.2  0.9 .01
Right common femoral artery 8.7  1.2 7.3  1.2 9.3  0.9 <.001
Left common iliac artery 10.4  1.6 9.4  1.6 10.9  1.4 .03
Left external iliac artery 8.5  1.3 7.4  0.9 9.2  1.1 .001
Left common femoral artery 8.6  1.2 7.5  1.1 9.2  0.9 .01
PAD, Peripheral arterial disease; SD, standard deviation.rgery c May 2009
Kurra et al Evolving TechnologyTABLE 3. Circumferential calcification and abdominal aortic aneurysm in the overall group and in the groups with (PAD group) and (no-PAD
group) criteria of significant PAD
Variable All patients (n ¼ 100) PAD group (n ¼ 35) noPAD group (n ¼ 65) P value (PAD vs no-PAD)
Infrarenal AAA (>3.5 cm) 5 (5%) 2 (6%) 3 (4%) .8
Infrarenal aorta<12 mm 6 (6%) 6 (17%) 0 (0%) .22
Circumferential calcification aortic
bifurcation (>60%)
12 (10%) 7 (20%) 5 (8%) .01
Circumferential calcification iliac
bifurcation (>60%)
12 (12%) 12 (34%) 0 (0%)* .2
PAD, Peripheral arterial disease; AAA, abdominal aortic aneurysm. *By definitionE
Tand will be the basis for evidence-based clinical guide-
lines.24,25
A limitation of precise measurements of luminal dimen-
sions with MDCT is partial volume averaging of calcium
(calcium blooming).26 Blooming of vessel wall calcification
is associated with overestimation of the calcified plaque area
and luminal stenosis. On the other hand, CT angiography is
not limited to a few angiographic planes but allows cross-
sectional measurements of the vessels at any point along
the vessel centerline.
MDCT is limited by the need for iodine-based contrast
administration. This is a serious limitation in the current
high-risk population, in which limiting the administration
of potentially nephrotoxic agents is of utmost importance.
Our group has systematically examined clinical characteris-
tics and outcome of patient with severe symptomatic aortic
stenosis in a similar but not identical patient population re-
ferred for percutaneous aortic valve replacement. In this
population of 92 patients, 10 (11%) had chronic kidney dis-
ease, defined as a serum creatinine level greater than 2 mg/
dL.27 The potential value of a noncontrast MDCT to assess
calcification and angulation of iliofemoral anatomy has not
been evaluated to date. MDCT is also associated with signif-
icant radiation exposure.28 Although it is generally impor-
tant to minimize radiation exposure, the risk of deleterious
effects is of less concern in this elderly and high-risk popu-
lation that is currently evaluated for pAVI.28
Our data describe results in 100 patients selected for pre-
operative MDCT assessment by the referring physician.
This population may be biased because of the exclusion
of patients with contraindications to CT. However, the pat-
tern is similar to a similar but not identical patient popula-
tion of patients with severe symptomatic aortic stenosis
referred for percutaneous aortic valve replacement. Our
group has systematically examined clinical characteristics
and outcome.27
CONCLUSION
Using CT angiography of the infrarenal abdominal aorta
and iliofemoral arteries, we demonstrated that more than
one third of patients with severe aortic stenosis evaluated
for pAVI had anatomic criteria unfavorable for transfemoralThe Journal of Thoracic and Caccess owing to atherosclerotic changes. CT angiography al-
lows preprocedural planning of arterial access. The clinical
impact on decision-making and outcome will need to be
evaluated in future controlled clinical trials.
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